Cloning,Expression,Purification and Its Biological Activity Study of a Novel GIP Analog

SONG Wen-cheng,JIN Ming-fei,LI Dong-qing,ZHAO Li-fen,ZHANG Hong-dan,HUANG Jing,WU Zi-rong
DOI: https://doi.org/10.13523/j.cb.20100607
2010-01-01
Abstract:Glucose-dependent insulinotropic polypeptide(GIP)is a forty-two amino acid hormone that stimulates the secretion of insulin from the pancreatic B-cells in the presence of elevated glucose concentrations.It's difficult to be applied because of its extremely short half life time.Modifying the dipeptidase IV recognition amino acid can prolong its half life time.Different GIP mutant genes that were obtained by artificial synthesizing or site-directed mutagenesis were cloned into the vector pET32a(+).These plasmids were expressed in Escherichia coli.The 6-histamine fused proteins were purified by NTA-Ni2+ affinity chromatography,respectively.Purified fusion proteins were then digested with enterokinase and purified with another affinity chromatography and desalting.The biological activities of GIP analogs were tested in vivo in Kuming mice or diabetic db/db mice at a dose of 48nmol/kg by intraperitoneal injection associated with injection of glucose at 18mmol/kg.The results showed that the half life time of analog mGIP243 in Kunming mice was extended to 90 minutes(P0.001),which was much longer than those of Ala to Ser analog mGIP2(30 minutes)or native GIP(shorter than 30 minutes).The oral glucose tolerance tests in Kuming mice and db/db mice both supported the results with a magnificent glucose lowering effects(p0.01 VS saline group)by the end of a 60 minutes test.Interestingly,the novel GIP analog mGIP243 played good glucose lowering effect in diabetic mice.In conclusion,the novel GIP analog mGIP243 is a good drug candidate for diabetes.
What problem does this paper attempt to address?